VistaGen Therapeutics to Participate in William Blair Biotech Focus Conference 2021
July 09 2021 - 8:30AM
VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company
committed to developing a new generation of medicines with the
potential to go beyond the current standard of care for anxiety,
depression, and other central nervous system (“CNS”) disorders,
today announced that management will participate in the ‘Updates in
Neuropsych’ panel at the virtual William Blair Biotech Focus
Conference 2021 on July 15, 2021 at 9:00 a.m. PT. VistaGen will
also be participating in one-on-one meetings throughout the
conference.
William Blair Biotech Focus Conference
2021
Panel: |
Updates in Neuropsych |
Date: |
Thursday, July 15 at 9:00 a.m. PT |
Webcast: |
https://wsw.com/webcast/blair59/panel8/2166208 |
Registration: |
To attend the virtual conference, please contact your William Blair
representative. |
The panel will be held virtually, and a live
webcast will be accessible through the News/Events page of the
Investors section of the company’s website at www.VistaGen.com.
About VistaGenVistaGen
Therapeutics is a biopharmaceutical company committed to developing
and commercializing innovative medicines with the potential to go
beyond the current standard of care for anxiety, depression, and
other CNS disorders. Each of VistaGen's three drug candidates has a
differentiated potential mechanism of action, has been
well-tolerated in all clinical studies to date, and has therapeutic
potential in multiple CNS markets. For more information, please
visit www.VistaGen.com and connect with VistaGen
on Twitter, LinkedIn, and Facebook.
Company ContactsMark A.
McPartland / Mark FlatherVistaGen Therapeutics, Inc.Phone: +1 (650)
577-3606/+1 (650) 577-3617Email: IR@vistagen.com
VistaGen Therapeutics (NASDAQ:VTGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
VistaGen Therapeutics (NASDAQ:VTGN)
Historical Stock Chart
From Apr 2023 to Apr 2024